Effect of baclofen on tardive dyskinesia
โ Scribed by J. Gerlach; T. Rye; P. Kristjansen
- Publisher
- Springer
- Year
- 1978
- Tongue
- English
- Weight
- 588 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In an attempt to determine the role of serotoninergic mechanisms in the pathophysiology of tardive dyskinesia, the serotonin precursor 5-hydroxytryptophan (5 HTP) with carbidopa, a peripheral decarboxylase inhibitor, were given in a double-blind crossover design to seven patients with longstanding t
A 55-year-old schizophrenic inpatient with buccolingual dyskinesia was treated with a single dose of ceruletide 0.8 gg/kg IM. Time-course effects of the drug were then followed for up to 6 weeks after injection. To assess changes in severity of bucco-lingual dyskinesia objectively, electromyogram (E
Twenty patients with signs of tardive dyskinesia secondary to antipsychotic medication participated in a double blind, controlled, parallel group study comparing codergocrine mesylate 4.5 mg once daily with a placebo. After 6 weeks medication a reduction in dyskinetic scores occurred in both groups,
Tardive dyskinesia (TD), a hyperkinetic disorder associated with long-term neuroleptic treatment, may be a manifestation of imbalance of opposing DA and ACh dependent systems in the CNS (i.e., hyperdopamine activity or hypoeholinergic function). Dopamine blocking agents give some transient relief of